Retailers and High Value Network Individuals (HNIs) would be in the wrong if Gland Pharma’s initial public offering (IPO) promoted by Fosun in China was lost. Shares of the Hyderabad-based company have gained 40 percent over its IPO price of 1,500 rupees. On Monday, the shares rose 15 percent to …
Read More »Gland Pharma Shares Make Strong Debut, Jumping Nearly 20%
Gland Pharma shares made a strong debut on the BSE and NSE today. His shares went up as much as ₹1,819 in EEB compared to the issue price of ₹1,500. The pharmaceutical company’s initial public offering (IPO), which closed on November 11, was signed twice. Of the company ₹The initial …
Read More »Gland Pharma IPO fully subscribed on the last day of subscription
Gland Pharma’s initial public offering was fully subscribed on the last day of subscription today. The numbers were subscribed 1.03 times as of 1:45 pm today. Gland Pharma’s IPO, the largest IPO of a pharmaceutical company in India, comprises a new issue of shares worth up to ₹1,250 crore and …
Read More »Fosun-owned Gland Pharma IPO price band is ₹ 1,490-1,500, offering opens Nov 9
NEW DELHI: Gland Pharma Ltd has set the price band for its initial public offering at ₹1,490-1,500 per share. The issue opens on November 9. The company plans to lift up to ₹Rs 1,250 crore by issuing new shares and allowing its China-based promoter Fosun Pharma Industrial Pte Ltd and …
Read More »